Transfusion Adverse Reaction: Clinical Trials

3 trials for Transfusion Adverse Reaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Transfusion Adverse Reaction: new trials by email Literature Review of Transfusion Adverse Reaction trials Research Report on Transfusion Adverse Reaction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Blood Storage Related Mortality and Adverse Effects in Trauma Patients
Transfusion Adverse Reaction, Major Trauma
CompletedKocaeli City Hospital1012026-01-172026-08-07
Incidence of Bleeding, Thrombosis and Transfusion Requirements in ICU Patients With COVID-19 Supported With Veno-venous Extracorporeal Membrane Oxygenation
VV ECMO, Bleeding
Not yet recruitingCopenhagen University Hospital, Rigshospitalet502026-01-012026-01-29
ECMO Hemostatic Transfusions in Children
Platelet Transfusion - Extracorporeal Membrane Oxygenation Complication, Hemorrhage
Phase 4CompletedYale University502023-12-122025-05-31

Narrower conditions

Hemorrhage (2)  ·  Thrombosis (2)  ·  COVID-19 (1)  ·  Thromboembolism (1)  ·  Wounds and Injuries (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Embolism and Thrombosis (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

Platelet Transfusion (1)

Sponsors

Copenhagen University Hospital, Rigshospitalet (1)  ·  Kocaeli City Hospital (1)  ·  Yale University (1)

Countries

United States (2)  ·  Denmark (1)  ·  Israel (1)

Top investigators

Marianne Nellis, MD, MS (1)  ·  Oliver Karam, MD, PhD (1)

Results publications

PMID 41432485

NIH funding

R34HL159119 (1)